Cargando…

Indian perspective of remdesivir: A promising COVID-19 drug

Detalles Bibliográficos
Autores principales:	Singh, Devendra, Wasan, Himika, Mathur, Apoorva, Gupta, Yogendra Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446682/ https://www.ncbi.nlm.nih.gov/pubmed/32874008 http://dx.doi.org/10.4103/ijp.IJP_486_20

Ejemplares similares

Drug development process and COVID-19 pandemic: Flourishing era of outsourcing
por: Wasan, Himika, et al.
Publicado: (2022)

Antimicrobial prescribing in dental practice during COVID 19: Its impact on antimicrobial resistance
por: Apoorva, Mathur, et al.
Publicado: (2021)

Influence of Qualification and Practice Settings of Dental Practitioners on Antimicrobial Prescribing in Delhi and National Capital Region, India
por: Wasan, Himika, et al.
Publicado: (2017)

Landscape of Push Funding in Antibiotic Research: Current Status and Way Forward
por: Wasan, Himika, et al.
Publicado: (2023)

Remdesivir and COVID-19
por: Ferrara, Francesco, et al.
Publicado: (2020)

Heme oxygenase-1 modulation: A potential therapeutic target for COVID-19 and associated complications
por: Singh, Devendra, et al.
Publicado: (2020)

Painful Blisters of Left Hand Following Extravasation of Remdesivir Infusion in COVID-19
por: Kumar, Neeraj, et al.
Publicado: (2021)

Pulmonary administration of remdesivir in the treatment of COVID-19
por: Rasmussen, Henrik Berg, et al.
Publicado: (2020)

Remdesivir for COVID-19: Why Not Dose Higher?
por: Yan, Victoria C., et al.
Publicado: (2021)

Remdesivir for the treatment of COVID-19: author's response
por: Lee, Todd C., et al.
Publicado: (2023)

Prediction of remdesivir resistance in COVID-19 illness: Need for development of clinical laboratory test
por: Kumar, Deepak, et al.
Publicado: (2021)

Liver injury in remdesivir-treated COVID-19 patients
por: Zampino, Rosa, et al.
Publicado: (2020)

Remdesivir versus ritonavir/lopinavir in COVID-19 patients
por: Vitiello, Antonio, et al.
Publicado: (2020)

Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir
por: Nakaya, Aya, et al.
Publicado: (2022)

Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir
por: Nakaya, Aya, et al.
Publicado: (2023)

Remdesivir induced bradycardia and QT prolongation: A rare side effect of a ubiquitous drug of the COVID -19 era
por: Singla, Karan, et al.
Publicado: (2022)

Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks?
por: Vitiello, Antonio, et al.
Publicado: (2021)

Remdesivir in moderate to severe COVID-19: A matter of time?
por: Bonazzetti, Cecilia, et al.
Publicado: (2021)

Re: Remdesivir for the treatment of COVID-19 by Lee et al.
por: Beccacece, Alessia, et al.
Publicado: (2023)

Remdesivir modifies interferon response in hospitalized COVID-19 patients
por: Murphy, Sarah L., et al.
Publicado: (2022)

COVID vaccination and mental health: An Indian perspective
por: Singh, Gurvinder Pal, et al.
Publicado: (2022)

Remdesivir in Breastfeeding
por: Sadati, Elham, et al.
Publicado: (2022)

Effect of Mask on Doctor–Patient Relationship during COVID-19: Indian Perspective
por: Banerjee, Sattwika, et al.
Publicado: (2022)

Does Remdesivir maintain the race in the general treatment protocol of COVID-19?
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2021)

Reply to Yan and Muller, “Remdesivir for COVID-19: Why Not Dose Higher?”
por: Juneja, Kavita, et al.
Publicado: (2021)

Written informed consent to virtual e-consent in clinical research: Changing necessity during COVID times
por: Mathur, Apoorva
Publicado: (2021)

Anaphylaxis Due to Remdesivir
por: Hopkins, Brian J., et al.
Publicado: (2021)

Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19)
por: Pallotto, Carlo, et al.
Publicado: (2021)

Simulation Based Learning: Indian Perspective
por: Singh, Tejinder Singh Swaran
Publicado: (2015)

Effects of the COVID-19 pandemic on post graduate gynecological training and surgical skills: Indian perspective
por: Sarkar, Avir, et al.
Publicado: (2021)

Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing
por: Trkulja, Vladimir
Publicado: (2021)

Remdesivir-associated bradycardia might be a sign of good prognosis in COVID-19 patients
por: Lucijanic, Marko, et al.
Publicado: (2022)

Successful management of remdesivir extravasation
por: Conde-Estévez, David, et al.
Publicado: (2022)

COVID-19 and Indian Pediatrics
por: Mishra, Devendra
Publicado: (2020)

A Patient with X-Linked Agammaglobulinemia and COVID-19 Infection Treated with Remdesivir and Convalescent Plasma
por: Iaboni, Aled, et al.
Publicado: (2021)

Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis
por: Lucijanic, Marko, et al.
Publicado: (2022)

Surgical Triage of Breast Disorders During the COVID-19 Pandemic: An Indian Perspective
por: Yelamanchi, Raghav, et al.
Publicado: (2020)

Status of Remdesivir: Not Yet Beyond Question!
por: Chatterjee, Saptarshi
Publicado: (2021)

Endocrine Society of India Fun Research Workshop 2015: The participants perspective
por: Chawla, Himika, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vkn0scgno9bpu0q2s62q6jl3fl